What actually helps sensitive teeth? The evidence is better than it used to be

The wince from a cold drink or a cold breath has a name — dentine hypersensitivity, pain from exposed dentine that no other dental problem explains — and the good news is that the evidence on what helps it has improved [s1] [s2]. For years the anchor was a Cochrane review of the classic desensitising ingredient, potassium, whose verdict was distinctly lukewarm [s1]. A larger, more recent network meta-analysis has since pulled several ingredients together and reached a firmer, if still qualified, recommendation: twice-daily toothpastes containing stannous, potassium or arginine can be recommended to reduce the pain [s2].

Why the classic evidence was so hedged

The Cochrane review tested potassium-containing toothpastes — potassium nitrate being the long-standing "sensitive teeth" formulation — against non-potassium control pastes in randomised trials [s1]. Six studies made it into the meta-analysis, and the result depended heavily on how sensitivity was measured [s1]. Prodding the tooth (tactile) and blowing air across it (air blast) both showed a statistically significant benefit at the six-to-eight-week mark: for air-blast sensitivity, the pooled standardised mean difference was 1.25 (95% confidence interval 1.65 to 0.851) in favour of the potassium paste [s1]. But when researchers simply asked participants how their teeth felt — the subjective assessment — the effect at six to eight weeks was not statistically significant [s1].

That split is the whole story of the review. When the outcome came from an instrument, potassium looked effective; when it came from the patient, it did not [s1]. Combined with a small total number of participants, that led the reviewers to a cautious bottom line: no clear evidence was available to support potassium-containing toothpastes for dentine hypersensitivity [s1]. It was never a finding that potassium fails — only that the trials were too few and too method-dependent to be sure [s1].

What the newer synthesis adds

The picture is no longer resting on those six trials. A 2023 network meta-analysis in the Journal of Dentistry set out to compare self-applied toothpastes properly, searching the literature to December 2022 and including 32 randomised trials with 4,638 participants, all in adults diagnosed with dentine hypersensitivity and assessed with at least two recognised stimuli [s2]. A network analysis lets formulations that were never tested head-to-head be compared indirectly, which is how it reaches across a fragmented field [s2].

Its conclusion is the most useful practical statement available: twice-daily application of a self-applied toothpaste containing stannous, potassium with or without stannous, or arginine can be recommended for reducing dentine hypersensitivity pain [s2]. That widens the shortlist beyond potassium alone to stannous (tin) and arginine formulations, and it grounds the recommendation in several times as many participants as the Cochrane review had [s2].

The caution that still applies

Neither the strength of the newer review nor its longer ingredient list should be oversold. The network meta-analysis itself flagged that dentine-hypersensitivity trials still lack a standardised methodology, and called for guideline development to improve how these studies are conducted, analysed and reported [s2]. Its comparisons are "short-term" by design, and much of the ranking rests on indirect evidence rather than direct trials [s2]. The measurement problem the Cochrane review exposed — that instrumented and subjective outcomes can disagree — has not disappeared [s1].

There is also a boundary the toothpaste aisle cannot police. Dentine hypersensitivity is defined as pain that "cannot be explained by any other form of dental disease" [s1]. A cracked tooth, a leaking filling, decay or gum recession can all mimic it, and a desensitising paste will do nothing for those. The reviews studied a specific diagnosis, not every twinge [s1].

What it means for a reader

The defensible summary is that desensitising toothpastes do help, and the evidence is better than the old potassium-only picture suggested: a network meta-analysis of 32 trials supports twice-daily stannous, potassium or arginine formulations for the pain, while the earlier Cochrane review is a reminder that the benefit can look larger on an instrument than it feels to the person, and that the trials remain imperfect [s1] [s2]. Used consistently, a formulated sensitivity toothpaste is a reasonable first step for the classic cold-triggered wince. But pain that is sharp, one-sided, lingering or worsening is exactly the kind the definition excludes — and belongs to a dentist, who can tell dentine hypersensitivity from the problems that imitate it, rather than to another tube.